Rheumatoid Arthritis. Rheumatoid arthritis with rheumatoid factor
Conditions
Interventions
Intervention 1: Intervention group: Group A: will be given 1 tablet (500 mg) of Habb-e-Asgand, twice daily after meals, with lukewarm water for 12 weeks. Intervention 2: Intervention group: Group B:
Sponsors
Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
Eligibility
Sex/Gender
All
Age
25 Years to 60 Years
Inclusion criteria
Inclusion criteria: Adults (aged 25–60 years) diagnosed with rheumatoid arthritis (RA) based on ACR/EULAR 2010 classification criteria Active disease symptoms with mild to moderate RA severity Ability to follow an exercise regimen Adherence to treatment. Patients with swelling in joints and pain
Exclusion criteria
Exclusion criteria: Severe or end-stage RA requiring surgical intervention Known allergies to herbal products or ingredients in Habb-e-Asgand Recent use of immunosuppressive drugs, other experimental therapies, or specific physiotherapy regimens. Pregnancy Lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 12 weeks. Method of measurement: WOMAC and NPRS scale.;Stiffness. Timepoint: 12 weeks. Method of measurement: WOMAC scale.;Daily activities. Timepoint: 12 weeks. Method of measurement: WOMAC scale.;Disease activity score. Timepoint: 12 weeks. Method of measurement: Disease Activity Score (DAS28). | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease in inflammatory biomarkers. Timepoint: 12 weeks. Method of measurement: ESR, CRP, RF.;Rheumatoid Arthritis Disability. Timepoint: 12 weeks. Method of measurement: Rheumatoid Arthritis Disability Index (RADI).;Swollen Joint Count. Timepoint: 12 weeks. Method of measurement: Xrays. | — |
Countries
Pakistan
Contacts
Public ContactMaliha Khalid Khan
Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
Outcome results
None listed